14
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Sustain Release Microsponge Based Drug Delivery System for the Plasmodium Treatment: Formulation Development and In vitro - In vivo Evaluation

&
Pages 205-216 | Received 09 Mar 2017, Accepted 11 Jan 2018, Published online: 02 May 2018

References

  • Medha, J., Sulabha, P., Shobhona, S., Vandana, P. (2008). Design and in vivo pharmaco-dynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject. Int. J. Pharm. 364: 119–26. doi: 10.1016/j.ijpharm.2008.07.032
  • Chang, C. (2014). Development of antimalarial drugs and their application in China: A historical review. Infectious Diseases of Poverty. 3(9): 1–10.
  • Antimalarial drug combination therapy: Report of a technical consultation (2001) WHO, GENEVA. 1-36.
  • Chinaeke, E.E., Chime, S.A., Onyishi, V.I., Attama, A. A., Okore, V.C. (2015). Formulation development and evaluation of the anti-malarial properties of sustained release artesunate-loaded solid lipid micro particles based on phytolipids. Drug Deliv. 22(5): 652–65. doi: 10.3109/10717544.2014.881633
  • Karbwang, J., Na-Bangchang, K., Congpuong, K., Molunto, P., Thanavibul, A. (1997). Pharmacokinetics and bioavailability of oral and intramuscular artemether. Eur. J. Clin. Pharmacol. 52: 307–10. doi: 10.1007/s002280050295
  • Hien, T.T., Davis, T.M., Chuong, L.V., Ilett, K.F., Sinh, D.X., Phu, N.H., Agus, C., Chiswell, G.M., White, N.J., Farrar, J. (2004). Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria. Antimicrobial Agents Chemother. 48: 4234–39. doi: 10.1128/AAC.48.11.4234-4239.2004
  • Riyaz Ali, M.O., Nagesh, H.A., Bharati, U.T., Parthasarathi, K.K., Afrasim, M., Umme, H., Atul, S., Rohit, R.B. (2015). Microsponge based drug delivery system for augmented gastroparesis therapy:Formulation development and evaluation. Asian J. Pharma. Sci. 10: 442–51. doi: 10.1016/j.ajps.2015.06.003
  • Siepmann, J., Siegel, R. A., Rathbone, M.J. (2012). Fundamentals and Applications of Control Release Drug Delivery. Springer. 1-594.
  • Won, R. (1987). Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen. US Patent No. 4690825. Washington, D.C. U.S. Patent and Trademark Office.
  • Ali, N., Mitra, J., Reza Siahi, M., Reza Mozafari, M. (2007). Factors affecting the morphology of benzoyl peroxide microsponges. Micron. 38: 834–40. doi: 10.1016/j.micron.2007.06.012
  • Parikh, B.N., Gothi, G.D., Patel, T.D., Chavda, H.V., Patel, C.N. (2010). Microsponge as novel topical drug delivery system. Journal of Global Pharma Tech. 2(1): 17–29.
  • Anil, P., Nitin, C., Nithya, G., Alaka, D., Arjun, K., Mala, K., Partha, K., Arvind, J., Dhanpat, K., Arun, C., Arnab, R. (2015) Sustained release formulation of primaquine for prevention of relapse of plasmodium vivax malaria: A randomized, double-blind, comparative, multicentric study. Malaria Research and Treatment Article ID 579864: 1-9.
  • Waterman, C.K. (2007). A critical review of gastric retentive controlled drug delivery. Pharm. Dev. Technol. 12: 1–10. doi: 10.1080/10837450601168680
  • Müge, K., Tamer, B. (2003). The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres. International J. Pharmaceutics. 252(1-2): 99–109. doi: 10.1016/S0378-5173(02)00630-0
  • Vikas, J., Ranjit Singh. (2010). Dicyclomine-loaded eudragit®-based microsponge with potential for colonic delivery: preparation and characterization. Tropical J. Pharma. Research. 9(1): 67–72.
  • Riyaz Ali, M.O., Nagesh, H.A., Dipti, J.I., Parthasarathi, K.K., Umme, H., Rohit, R.B., Dandasi, J.D. (2015). Microsponges based novel drug delivery system for augmented arthritis therapy. Saudi Pharmaceutical Journal. 23: 562–72. doi: 10.1016/j.jsps.2015.02.020
  • Ali, N., Mitra, J., Reza Siahi, M., Reza Mozafari, M. (2007). Factors affecting the morphology of benzoyl peroxide microsponges. Micron. 38: 834–40. doi: 10.1016/j.micron.2007.06.012
  • Comoglu, T., Savaser, A., Ozkan, Y., Gonul, N., Baykara, T. (2007). Enhancement of ketoprofen bioavailability by formation of microsponge tablets. Phazie. 62: 51–54.
  • Atmaram, P. P., Aditya, P. G., Ashwin, B. K., Bothiraja, C., Ashwin, J. M. (2015). Formulation and evaluation of optimized oxybenzone microsponge gel for topical delivery. J. Drug Deli.Article ID 261068: 1–9.
  • Vikas, G.R., Shubhangi, K.S., Abhijeet, A., Varsha, P. (2015). Tablet formulation and enhancement of aqueous solubility of carisoprodol by solvent evaporation co-crystal technique. Analytical Chem. Lett. 5(6): 364–376. doi: 10.1080/22297928.2015.1129288
  • Vikas, G.R., Sambhajik, Z., Vilas, B.G., Inayat, B.P. (2015). The development, evaluation and in vitro release study of the terbinafine transdermal patch. Ind. Chem. 1(2): 1–6.
  • Kirti, D., Poddar, S.S. (2012). Tyrosinase inhibitor-loaded microsponge drug delivery system: New approach for hyper pigmentation disorders. J. Microencapsulation: Micro and nano carriers. 29(6): 559–68. doi: 10.3109/02652048.2012.668955
  • Sha-Sha, L., Guo-Feng, L., Li, L., Xiao, J., Bin, Z., Zhi-Gang, L., Xue-Ling, L., Li-Dong, W., Ting, Z., Qiang, L. (2013). Evaluation of paeonol skin-target delivery from its microsponge formulation: In vitro skin permeation and in vivo microdialysis. PLOS ONE. 8(11): e79881.
  • Mine, O., Erdal, C., Ahmet, A. (2006). Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. International J. Pharmaceutics. 318(1-2): 103–17. doi: 10.1016/j.ijpharm.2006.03.025
  • Raghavendra, V.K., Yogesh, J.W., Mallikarjun, Setty. C., Biswanath, S. (2011). Development and characterization of sodium alginate-hydroxypropyl methylcellulose-polyester multilayered hydrogel membranes for drug delivery through skin. Polymer-Plastics Technology and Engineering. 50: 490–97. doi: 10.1080/03602559.2010.543244
  • Sabyasachi, M., Santanu, K., Somasree, R., Biswanath, S. A. (2011). Development and evaluation of xanthan gum-facilitated ethyl cellulose microsponges for controlled percutaneous delivery of diclofenac sodium. Acta Ph. 61: 257–70.
  • Vikas, G.R., Ravikumar, D.G., Vilas, B.G. (2015). Development of naproxen co crystal formation: an efficient approach to enhance aqueous solubility. Analytical Chem. Lett. 5(4): 229–238. doi: 10.1080/22297928.2015.1128850
  • Priyanka, A., Biswajit, M. (2002). Design, Development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J. Pharma. Sci. 91(9): 2076–89. doi: 10.1002/jps.10200
  • Thatipamula, R.P., Palem, C.R., Gannu, R., Mudragada, S., Yamsani, M.R. (2011). Formulation and in vitro characterization of domperidone loaded solid lipid nano particles and nano-structured lipid carriers. DARU. 19(1): 23–32.
  • Christianne Mounir, Z.R., Randa latif, A., Iman, I.S. (2011). In vitro and in vivo evaluation of hydroxyzine hydrochloride microsponges for topical delivery. AAPS Ph Sci Tech. 12(3). 989–1001.
  • Tansel, Çomoglu., Nursin, G., Tarmer, B. (2003). Preparation and in vitro evaluation of modified release ketoprofen microsponges. I1 Faco. 58(2): 101–106.
  • Venugopalarao, G., Lakshmipathy, R., Ganesh, G., Sarada, N.C. (2015). J. Absorption and bioavailability of cefditoren pivoxil in hydrogels in vitro and in vivo. Taibah Uni. Science. 9: 1–6. doi: 10.1016/j.jtusci.2014.04.005

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.